Skip to main content
. 2021 Apr 8;9(4):e002230. doi: 10.1136/jitc-2020-002230

Table 2.

Multivariate analysis (dependent variable: TPS, independent variables: age, gender, primary, metastatic sites, subtypes)

TPS <50% (reference) vs TPS ≥50%
Variables All subtypes Non-squamous NSCLC LUSC
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Age
 <50 years Reference 0.737 Reference 0.711 Reference 0.046*
 ≥50 years 0.97 (0.82 to 1.15) 1.03 (0.86 to 1.24) 0.61 (0.37 to 0.99)
Gender
 Male Reference 0.027* Reference 0.184 Reference 0.015*
 Female 1.08 (1.01 to 1.16) 1.05 (0.98 to 1.14) 1.23 (1.04 to 1.44)
Bx site
 Primary Reference <0.001* Reference <0.001* Reference 0.197
 Metastatic 1.28 (1.19 to 1.37) 1.37 (1.27 to 1.49) 0.89 (0.74 to 1.06)
Primary (reference) vs metastatic site
Lymph node 1.58 (1.43 to 1.74) <0.001* 1.80 (1.61 to 2.00) <0.001* 0.83 (0.63 to 1.08) 0.163
Liver 0.98 (0.83 to 1.16) 0.835 1.03 (0.86 to 1.24) 0.75 1.21 (0.79 to 1.87) 0.385
Brain 1.00 (0.85 to 1.18) 0.994 1.02 (0.85 to 1.21) 0.842 0.96 (0.51 to 1.81) 0.903
Pleural fluid 1.48 (1.23 to 1.78) <0.001* 1.53 (1.27 to 1.84) <0.001* 0 (0 to 3.24e+166) 0.95
Soft tissue 1.30 (1.08 to 1.58) 0.007* 1.44 (1.17 to 1.79) 0.001* 0.92 (0.58 to 1.47) 0.73
Bone 0.83 (0.67 to 1.04) 0.101 0.81 (0.64 to 1.02) 0.073 0.87 (0.45 to 1.69) 0.684
Pleura 1.12 (0.89 to 1.40) 0.343 1.14 (0.89 to 1.45) 0.288 0.83 (0.39 to 1.77) 0.628
Adrenal gland 1.70 (1.30 to 2.22) <0.001* 1.66 (1.24 to 2.21) 0.001* 2.04 (0.87 to 4.76) 0.1

*p < 0.05

LUSC, lung squamous cell carcinoma; NSCLC, non-small cell lung cancer; TPS, tumor proportion score.